To test whether the presence of high amounts of extracellular matrix overexpressed in ECM3 tumors could impact trastuzumab diffusion and antitumor activity, the HER2-amplified carcinoma cell line SKOV3 was injected in nude mice with or without Matrigel and then treated with trastuzumab (Figure 4a).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}